Dr. Maldonado joins Koya as Chief Medical Officer and member of the Medical Advisory Board
Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced the addition of Dr. Thomas Maldonado as Chief Medical Officer. The addition of Dr. Maldonado further strengthens Koya Medical’s clinical advisory board, led by Stanley Rockson, M.D., cardiologist and professor in the Falk Cardiovascular Research Center at Stanford University School of Medicine.
Thomas Maldonado, M.D. has been one of New York City’s top vascular surgeons in one of the nation’s premier academic medical centers for over two decades. He is regularly featured as Top Doctor by Castle Connolly and has served as president of numerous national and regional vascular societies. Dr. Maldonado, who is devoted to unrivaled patient care and research, states that he is “honored to serve as Chief Medical Officer for Koya Medical and looks forward to continuing to advance the Dayspring to help even more people with lymphedema and venous diseases maintain mobility while receiving effective compression treatment.”
Dr. Maldonado, Professor of Surgery, is a prolific researcher and academician with over 150 publications in the field of vascular surgery and serves as editor-in-chief for the journal, Vascular and Endovascular Surgery. Additionally, Dr. Maldonado is an innovator in minimally invasive endovascular therapy. He is nationally and internationally recognized for his surgical skill as well as his commitment to education and advancing patient care.
Dayspring is the first and only non-pneumatic active dynamic compression treatment designed for patient mobility and cleared by the U.S. Food and Drug Administration (FDA) to treat lymphedema and chronic venous conditions.
Source: Koya Medical
